Medications started in the ER for alcohol use disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether starting certain medications in the emergency room can help people with moderate to severe alcohol use disorder reduce heavy drinking and withdrawal problems after they leave the ER. It compares outcomes for participants who receive the study medications soon after an ER visit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 80
- You have been diagnosed with moderate to severe alcohol use disorder
- You are able and willing to follow study steps and stay available for the whole study
- You must speak English enough to understand the study and sign consent
- Your alcohol withdrawal symptoms score high enough on a CIWA-Ar test (score 4 or higher)
- If you can become pregnant, you need a recent negative pregnancy test and must use very effective birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This study tests whether the medication nimodipine (usually used for blood pressure) can help people who drink heavily reduce how much they drink. If you join, you may receive the medication or a placebo (a pill with no active ingredient) and take part in drinking sessions to see how it affects you.
This study tests whether a new medication called NTX-2001 can help people with alcohol use disorder drink less. Researchers will measure how the drug affects alcohol consumption and safety in adults aged 21–60.
This study tests if a blood-pressure medicine called nimodipine can help people who drink heavily reduce their alcohol intake. The trial involves lab-based drinking sessions and brain scans to understand how the drug works on the brain.
This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.
This study tests whether combining two medications—one that helps control cravings and one that affects appetite and reward—can help people reduce or stop drinking alcohol. If you are in treatment for alcohol use disorder收, this may offer a new way to support your recovery.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.